Metal index, which forms 4 per cent of the Nifty 50 index, surged as much as 1.6 per cent and pulled Nifty to trade in green with marginal gains. We hold 3,740 followed by 3,820 as the immediate resistances while 3,670 followed by 3,570 is expected to act as the supports if index retreats.

Suven Life Sciences Limited received Establishment Inspection Report (EIR) from the US drug regulator for its Pashamylaram, Medak facility.

To counter rising raw material prices, tyre makers have opted for a price hike of their products in the range of around 2.5 to 3 per cent. 

Following stocks are close to their 52-week low as at 1.12 p.m. on May 7, 2018.

The markets on May 7, 2018 opened gap up. BSE Sensex is trading at 35,132.31, up by 216.93 points and the Nifty is trading at 10,676.40, up by 58.15 points.

Manpasand Beverages and Parle Products are planning to jointly distribute their respective brands in western markets, starting with Gujarat.

Agrochemical company Crystal Crop Protection filed its draft papers with the market regulator SEBI to raise an initial public offering worth Rs. 1,000 crore.

When almost all the sectoral indices have supported the benchmark indices in its marginal upswing, the Nifty Pharma index, continued to fall shedding more than 0.5 per cent. Recently, it has bounced back from 50 per cent retracement of an upward rally from double bottom. However, we can expect fresh buying in the index only above 9,100 levels.

Real estate major Lodha Developers is buckling up to file its draft prospectus with SEBI to launch its IPO soon, according to reports. The initial public offering is expected to be one of the most notable debuts in the Indian stock this year. 

The PAT for the quarter came in at Rs. 12.77 crore, yoy decline of 23.5 per cent. This was due to sharp jump in interest expenses by 72.8 per cent yoy.